Mark A. Katz

Mark A. Katz is an Adjunct Clinical Associate Professor in the Department of Epidemiology at the University of Michigan School of Public Health. He concurrently serves as adjunct clinical associate professor at Ben Gurion University of the Negev, Head of Infectious Diseases at Clalit Research Institute in Tel Aviv, and WHO consultant for vaccine-preventable diseases.

His educational background includes:

• Epidemic Intelligence Service, US Centers for Disease Control and Prevention (2004-2006)
• Internal Medicine/Primary Care Residency, New York University School of Medicine (2001-2004)
• MD, Mount Sinai School of Medicine (2001)
• BA, University of Michigan (1992)

Dr. Katz's research centers on infectious disease epidemiology in global contexts, with primary focus on influenza vaccine effectiveness in healthcare workers, water sanitation evaluations in southern Israel, functional health literacy among uninsured foreign residents, and systematic reviews of influenza complications in pregnant women. His work consistently involves cross-institutional collaborations between Clalit Research Institute, Ben Gurion University, CDC, WHO, and University of Michigan across Kenya, Haiti, and Israel.

His publication record demonstrates sustained expertise in vaccine-preventable disease surveillance, with recent work analyzing influenza vaccine formulations for Kenya, cholera vaccination barriers in Haiti, and pediatric influenza vaccine effectiveness in diverse Kenyan settings. This research directly informs public health interventions in resource-limited regions through evidence-based vaccine policy development.

Professional experience includes leadership roles as head of infectious disease surveillance at CDC-Haiti (2011-2013) and head of regional influenza programs at CDC-Kenya (2006-2011), showcasing extensive field implementation of epidemiological systems during critical public health responses.